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A 77‐year‐old Japanese man admitted to our hospital due to pneumonia. Chest computed tomography incidentally showed calcifications of left ventricular endomyocardium (Figure [1](#jgf2246-fig-0001){ref-type="fig"}A). He had no remarkable medical history including tuberculosis, malignancy, radiotherapy, and heart disease. He had no record of overseas travel. White blood cell count was 5600/μL, and the absolute eosinophil count was 151/μL. Serum total protein, albumin, creatinine, calcium, phosphorus, the 25‐hydroxyvitamin D, and parathyroid hormone level were within normal range, and body mass index was 21.0 kg/m^2^. Electrocardiogram showed sinus rhythm, ST depression with inverted T wave in leads V5 and V6, and high electric potential of RV5 + SV1 (Figure [1](#jgf2246-fig-0001){ref-type="fig"}B). Echocardiography revealed sporadic endomyocardial calcifications predominantly around the apex with apical obliteration, and E/e' index was elevated to 18.3 (Figure [1](#jgf2246-fig-0001){ref-type="fig"}C). Cardiac magnetic resonance imaging showed endomyocardial calcification (Figure [1](#jgf2246-fig-0001){ref-type="fig"}D), and delayed imaging revealed the area of patchy intramyocardial gadolinium enhancement (Figure [1](#jgf2246-fig-0001){ref-type="fig"}E). Coronary angiography revealed no stenosis. Histopathology by endomyocardial biopsy from the right ventricle demonstrates fibrotic thickness of the endocardium due to the proliferation of acellular collagen (Figure [2](#jgf2246-fig-0002){ref-type="fig"}A,B), but in the absence of eosinophilic infiltration. On the basis of these results, we diagnosed biventricular endomyocardial fibrosis (EMF) with chronic fibrotic change or calcification.
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Although EMF is a progressive restrictive cardiomyopathy frequently observed in tropical countries, it is poorly understood disease in developed countries because of its low incidence.[1](#jgf2246-bib-0001){ref-type="ref"}, [2](#jgf2246-bib-0002){ref-type="ref"} The clinical manifestations of EMF, which is characterized by fibrous endomyocardial hypertrophy and calcification in the ventricle, is related to the presence of heart failure. Since the appropriate treatments have not yet been established, the prognosis of EMF is poor, with a mortality estimated at 25% per year.[3](#jgf2246-bib-0003){ref-type="ref"} EMF should be considered as a differential diagnosis when physicians encounter a patient presenting with calcification in the ventricle, or heart failure due to restrictive cardiomyopathy, even in an elderly patient.
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